Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,890 | -21,494 | -91,863 | -65,731 | -41,211 |
| Depreciation Amortization | 1,958 | 1,017 | 4,606 | 3,504 | 2,424 |
| Income taxes - deferred | -59 | -21 | 6,180 | 2,037 | 1,272 |
| Accounts receivable | -52 | 288 | 149 | -210 | -2,238 |
| Accounts payable and accrued liabilities | -669 | 679 | -1,206 | -863 | 607 |
| Other Working Capital | -10,569 | -5,396 | -26,988 | -18,007 | -16,223 |
| Other Operating Activity | 10,335 | 4,326 | 20,266 | 14,710 | 11,257 |
| Operating Cash Flow | $-44,946 | $-20,601 | $-88,856 | $-64,560 | $-44,112 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -821 | -2,119 | -5,154 | -3,382 | -1,453 |
| Purchase Of Investment | -155,142 | -121,152 | -260,435 | -241,397 | -140,626 |
| Sale Of Investment | 156,174 | 85,749 | 354,530 | 313,398 | 233,678 |
| Investing Cash Flow | $211 | $-37,522 | $88,941 | $68,619 | $91,599 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,626 | 617 | 82,054 | 79,514 | 61,396 |
| Financing Cash Flow | $1,626 | $617 | $82,054 | $79,514 | $61,396 |
| Exchange Rate Effect | -104 | 171 | 543 | 535 | N/A |
| Beginning Cash Position | 158,082 | 158,082 | 75,400 | 75,400 | 75,400 |
| End Cash Position | 114,869 | 100,747 | 158,082 | 159,508 | 184,283 |
| Net Cash Flow | $-43,213 | $-57,335 | $82,682 | $84,108 | $108,883 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,946 | -20,601 | -88,856 | -64,560 | -44,112 |
| Capital Expenditure | -825 | -2,119 | -5,154 | -3,382 | -1,453 |
| Free Cash Flow | -45,771 | -22,720 | -94,010 | -67,942 | -45,565 |